Matthew Kobylinski 1 2, Nina Krupa 1 2, Hollis Tam 1, Linda Nguyen 1, Julia R Jahansooz 1 2, Kylie Herndon 1 3, Kaelyn Pacpaco 1 4, Masako Matsunaga 2, Samuel Toh Kim 1, Qi Zhi 1, Michael Sonson 1,…
Blood Biomarkers, Latest Treatments, and Brain Health Insights Alzheimer’s disease is one of the most talked-about—and misunderstood—neurological conditions today. With constant news headlines, social media discussions, and emerging research, patients and families are often left confused about what is true,…
DEBUNKING MYTHS, MISINFORMATION, CONTROVERSIES ON ALZHEIMER’S BLOOD BIOMARKERS, LATEST TREATMENTS & BRAIN HEALTH TIPS from US POINTER STUDY. This week on KHON2’s Working For Hawaii: Unscripted, we sat down with Dr. Kore Liow, a neurologist and Alzheimer’s expert, for an…
Hawaii Memory & Alzheimer’s Research has joined leading academic institutions—including UCSF, UC San Diego, and the Cleveland Clinic—in a multicenter clinical trial investigating VHB937, a novel TREM2-stabilizing monoclonal antibody engineered to cross the blood–brain barrier and reduce neuroinflammation in Alzheimer’s…
ERP Biomarkers of Cognitive Dysfunction in Alzheimer’s Disease: Real-World Evidence Supporting Translational Clinical Trial Endpoints Advances in neuroscience and digital biomarkers are transforming how clinicians and researchers detect, monitor, and study Alzheimer’s disease (AD). At the 2025 Clinical Trials on…
Brainshuttle™ Launched in Hawaii! Novel Alzheimer’s Drug Trontinemab with Brainshuttle™ Technology A new Alzheimer’s clinical study using the investigational drug trontinemab, engineered with Brainshuttle™ technology, is now accepting participants in Hawaii. This approach aims to achieve rapid amyloid clearance with…